Journals / The Journal of Pediatric Research / 2019 / Cilt: 6 - Sayı: 2

Visceral Leishmaniasis in Children in Southern Turkey: Evaluation of Clinical and Laboratory Findings and Liposomal Amphotericin B Treatment

Pages
110–114
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additionally, recent migration from themiddle-eastern region to western parts of the world due to regional civil wars may have contributed to the observed increase in the incidenceof various diseases such as VL.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Visceral leishmaniasis (VL) is a systemic infection that spreads hematogenously and affects the reticuloendothelial system by theinfection of macrophages.
📊
Key Findings & Data:VL should be considered in patients with prolonged highfever, hepatosplenomegaly, pancytopenia, weight loss, pallor and hypergammaglobulinemia.Materials and Methods: In this study, a total of 18 pediatric patients -9 (50%) males and 9 (50%) females- treated for VL at our clinic fromJanuary 2004 to July 2014 were analyzed retrospectively.
💡
Conclusion & Impact:Additionally, recent migration from themiddle-eastern region to western parts of the world due to regional civil wars may have contributed to the observed increase in the incidenceof various diseases such as VL.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Özet

Aim: Visceral leishmaniasis (VL) is a systemic infection that spreads hematogenously and affects the reticuloendothelial system by theinfection of macrophages. VL occurs commonly in children, and only rarely in adults. VL should be considered in patients with prolonged highfever, hepatosplenomegaly, pancytopenia, weight loss, pallor and hypergammaglobulinemia.Materials and Methods: In this study, a total of 18 pediatric patients -9 (50%) males and 9 (50%) females- treated for VL at our clinic fromJanuary 2004 to July 2014 were analyzed retrospectively. Average time from symptom onset to hospital admission was 64±21 days (range:30-100 days). The mean age of patients was 88±40 months (range: 36-182 months).Results: The most common symptom at presentation was fever (88.9%). Other common symptoms were fatigue, chills, weight lossand anorexia. Physical examination revealed splenomegaly and hepatomegaly in all patients. Anemia (92.4%), leukopenia (78.7%) andthrombocytopenia (76.2%) were the most prominent laboratory abnormalities and 82.2% of the patients were pancytopenic on admission.Bone marrow smear was positive for leishmania in 100% of the patients. All patients received treatment with liposomal amphotericin B.Conclusion: In certain regions, increased humidity rates associated with construction of dams and irrigation canals may lead to changes inthe ecological balance and thus cause an increase in the population of disease-spreading vectors. Additionally, recent migration from themiddle-eastern region to western parts of the world due to regional civil wars may have contributed to the observed increase in the incidenceof various diseases such as VL.

🔖

Cite This Article

ÖZGÜR, Ö., ŞAŞMAZ, İ., ANTMEN, B., KOCABAŞ, E., ALHAN, E., KARAGÜN, B. Ş. (2019). Visceral Leishmaniasis in Children in Southern Turkey: Evaluation of Clinical and Laboratory Findings and Liposomal Amphotericin B Treatment. The Journal of Pediatric Research, Cilt: 6 - Sayı: 2, 110–114. https://ajindex.com/articles/362885

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Kurşun E, Turunç T, Demiroğlu YZ, Solmaz S, Arslan H. Evaluation of fourteen adult cases with visceral leishmaniasis. Mikrobiyol Bul 2013;47:500-6
  2. Ozensoy S, Ozbel Y, Turgay N, et al. Serodiagnosis and epidemiology of visceral leishmaniasis in Turkey. Am J Trop Med Hyg 1998;59:363-9
  3. Mathers CD, Ezzati M, Lopez AD. Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dise 2007;1:e114
  4. Gürel MS, Yesilova Y, Ölgen MK, Özbel Y. Cutaneous leishmaniasis in Turkey. Türkiye Parazitolojii Dergisi 2012;36:121
  5. Karimkhani C, Wanga V, Coffeng LE, Naghavi P, Dellavalle RP, Naghavi M. Global burden of cutaneous leishmaniasis: a crosssectional analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis 2016;16:584-91
  6. Abdinia B, Oliaei-Motlagh M, Teimouri-Dereshki A. Pediatric visceral leishmaniasis in northwest of Iran. Medicine (Baltimore) 2016;95:e5261
  7. Totan M, Dagdemir A, Muslu A, Albayrak D. Visceral childhood leishmaniasis in Turkey. Acta paediatr 2002;91:62-4
  8. Maltezou HC, Siafas C, Mavrikou M, et al. Visceral leishmaniasis during childhood in southern Greece. Clin Infect Dis 2000;31:1139- 43
  9. Minodier P, Garnier J. Childhood visceral leishmaniasis in Provence. Arch Pediatr 2000;7:572-7
  10. Miao R, Wang Z, Guo Q, et al. Clinical and epidemiologic features of visceral leishmaniasis in children in southwestern china: A retrospective analysis from 2001 to 2015. Pediatr Infect Dis J 2017;36:9-12
  11. Krepis P, Krepi A, Argyri I, et al. Childhood visceral leishmaniasis: distinctive features and diagnosis of a re-emerging disease. An 11-year experience from a tertiary referral center in Athens, Greece. Pediatr Infect Dis J 2018;37:419-23
  12. Kafetzis DA, Velissariou IM, Stabouli S, Mavrikou M, Delis D, Liapi G. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds? Int J Antimicrob Agents 2005;25:26-30
  13. Kafetzis DA. An overview of paediatric leishmaniasis. J Postgrade Med 2003;49:31-8
  14. Hamid GA, Gobah GA. Clinical and hematological manifestations of visceral leishmaniasis in Yemeni children. Turk J Hematol 2009;26:25-8
  15. Guerrant RL, Walker DH, Weller PF. Tropical infectious diseases: principles, pathogens and practice (Expert Consult--Online and Print), 3e: Saunders; 2011
  16. Jha TK, Olliaro P, Thakur CP, et al. Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral lei